Articles, guides, and regulatory updates from our community.
New research explores how IL-15 and Thymosin α1 may reduce immune cell aging in hepatocellular carcinoma. Learn what the findings mean for patients.
By Peptide Association Research Team
New research suggests IL-15 combined with Thymosin α1 may reverse immune cell aging in hepatocellular carcinoma. Learn what the study found and why it matters.
By Peptide Association Research Team